|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,365 KRW | -2.35% |
|
-9.63% | -36.46% |
| 24/01 | Elevance Health Offers Stronger-Than-Expected 2024 Earnings Outlook After Fourth-Quarter Beat | MT |
| 24/01 | Elevance Health Issues Upbeat 2024 Adjusted. Earnings Outlook After 4Q Revenue Gains | DJ |
BioPlus Co., Ltd. (KOSDAQ:A099430) announces a share repurchase program. Under the program, the company will repurchase up to 5,000 million worth of its shares according to the trust contract with Korea Investment & Securities Co., Ltd. The purpose of the program is to enhance shareholder value and stabilize stock price. The program will expire on April 13, 2022.
As of October 12, 2021, the company had 0 share in treasury within the scope available for dividend and under other repurchases.
| 1st Jan change | Capi. | |
|---|---|---|
| -36.46% | 18Cr | |
| -2.29% | 8.99TCr | |
| -3.95% | 3.76TCr | |
| -13.07% | 3.28TCr | |
| +63.05% | 2.65TCr | |
| -22.14% | 1.43TCr | |
| -7.96% | 1.3TCr | |
| -9.33% | 1.19TCr | |
| -46.33% | 1.08TCr | |
| +5.77% | 911.12Cr |
BIO PLUS CO., LTD 
